Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHAMPION PLATFORM: Cangrelor vs Usual Care in PCI
NCT00385138Phase 3Terminated
- Sponsor
- The Medicines Company
- Start
- Sep 2006
- Primary completion
- May 2009
- Modality
- Nucleic Acid-Directed Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of cangrelor in acute coronary syndrome (ACS), atherosclerosis, sponsored by The Medicines Company. Started Sep 2006; status: terminated.
02
Drugs
cangrelor
03
Conditions
acute coronary syndrome (ACS)atherosclerosis
Beyond the preview
Go deeper on NCT00385138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00385138.